Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Amidotrizoic Acid USP was classifiable as a pharmaceutical chemical under Heading 29.01/45(13) of the Customs Tariff Act, 1975 and, if so, whether it was eligible for exemption under Notification No. 33/83.
Analysis: For classification under Heading 29.01/45(13), the goods had to be pharmaceutical chemicals having prophylactic or therapeutic value and used solely or predominantly as drugs. The imported material, though conforming to USP standards, was shown by the pharmacopoeial literature to be used as a contrast medium in diagnostic radiology and for procedures such as urography and angiography. That use amounted to a diagnostic aid rather than a curative or preventive medicine. The endorsement of the Assistant Drug Controller did not establish the necessary prophylactic or therapeutic value. The benefit of Notification No. 234/82-C.E. for bulk drugs did not govern classification under the Customs Tariff, because that notification covered a wider description and its Explanation embraced diagnostic chemicals conforming to pharmacopoeial standards. The claimed exemption under Notification No. 33/83 depended on satisfaction of the tariff heading itself.
Conclusion: The goods were not classifiable under Heading 29.01/45(13) and were not entitled to exemption under Notification No. 33/83.